Klaus Kopka

17.8k citations
284 papers · 13.1k indexed · 11 hit papers · h-index 55
Topics
Radiopharmaceutical Chemistry and Applications (152 papers)Prostate Cancer Treatment and Research (96 papers)Peptidase Inhibition and Analysis (60 papers)
Journals
Journal of the American Chemical SocietyCirculationSHILAP Revista de lepidopterología

In The Last Decade

Klaus Kopka

273 papers receiving 12.9k citations

Hit Papers

The diagnostic value of PET/CT imaging with the 68Ga-labe...201420262018202220142016201720152016250500750

Peers

Klaus Kopka
Comparison fields: 5 of 145
  • Radiology, Nuclear Medicine and Imaging 8.8k
  • Pulmonary and Respiratory Medicine 8.2k
  • Oncology 3.4k
  • Molecular Biology 1.7k
  • Cancer Research 1.4k
Replace Johannes Czernin with:
Johannes Czernin United States
Hans‐Jürgen Wester Germany
John W. Babich United States
François Bénard Canada
Scott T. Tagawa United States
Emmanuel S. Antonarakis United States
Kim N. Canada
Philip J. Blower United Kingdom
Michael A. Gorin United States
Cristina Müller Switzerland
Klaus Kopka relative to Johannes Czernin United States Johannes Czernin's profile →
Citations per field
00.5×1.6×
Johannes Czernin · 1×
Citations per year

Countries citing papers authored by Klaus Kopka

Since Specialization
Citations

This map shows the geographic impact of Klaus Kopka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Kopka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Kopka more than expected).

Fields of papers citing papers by Klaus Kopka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Kopka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Kopka. The network helps show where Klaus Kopka may publish in the future.

Co-authorship network of co-authors of Klaus Kopka

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Kopka. A scholar is included among the top collaborators of Klaus Kopka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Kopka. Klaus Kopka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 3
5 2
6 1
7 0
8 3
9 1
10 6
11 4
12 0
13 1
14 21
15 27
16 7
17 24
18 49
19 4
20 6

About Klaus Kopka

Klaus Kopka is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 284 papers that have together received 13.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (152 papers), Prostate Cancer Treatment and Research (96 papers) and Peptidase Inhibition and Analysis (60 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (8.8k citations), Pulmonary and Respiratory Medicine (8.2k citations) and Oncology (3.4k citations). Klaus Kopka has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Uwe Haberkorn, Clemens Kratochwil, Frederik L. Giesel, Matthias Eder, Ali Afshar‐Oromieh, Walter Mier, Martin Schäfer, Martina Benešová, Boris Hadaschik and Michael Schäfers. Their work appears in journals such as Journal of the American Chemical Society, Circulation and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026